Guangdong Hec Technology Holding Co Ltd
SSE:600673
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guangdong Hec Technology Holding Co Ltd
EPS (Diluted)
Guangdong Hec Technology Holding Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Guangdong Hec Technology Holding Co Ltd
SSE:600673
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
8%
|
|
|
C
|
China Hongqiao Group Ltd
HKEX:1378
|
EPS (Diluted)
¥2
|
CAGR 3-Years
36%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Aluminum Corporation of China Ltd
SSE:601600
|
EPS (Diluted)
¥0
|
CAGR 3-Years
46%
|
CAGR 5-Years
90%
|
CAGR 10-Years
54%
|
|
|
Shandong Hongchuang Aluminum Industry Holding Co Ltd
SZSE:002379
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-157%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
6%
|
|
|
Yunnan Aluminium Co Ltd
SZSE:000807
|
EPS (Diluted)
¥1
|
CAGR 3-Years
10%
|
CAGR 5-Years
43%
|
CAGR 10-Years
56%
|
|
|
Tianshan Aluminum Group Co Ltd
SZSE:002532
|
EPS (Diluted)
¥1
|
CAGR 3-Years
23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
Guangdong Hec Technology Holding Co Ltd
Glance View
Nestled in the vibrant economic landscape of China, Guangdong Hec Technology Holding Co Ltd operates with the intricacies of a well-oiled machine in the health sector. The company, with its focal point in pharmaceuticals, has been a significant player in the development, manufacturing, and sale of a variety of medicinal products. Its portfolio spans across anti-infectives, digestive medications, and cardiovascular treatments, amassing a reputation for innovation and quality. The company’s commitment to research and development is palpable, as it consistently invests in state-of-the-art laboratories and collaborations with leading scientific minds. This approach not only fuels its pipeline of groundbreaking therapies but also ensures a steady stream of products ready for market. The company's revenue engine hums efficiently through a strategic blend of domestic and international market penetration. By leveraging an extensive distribution network, Guangdong Hec Technology ensures its products reach both regional pharmacies and global pharmaceutical markets. Through meticulous marketing strategies and strategic partnerships, the company has adeptly navigated the complex waters of regulatory compliance and competitive pricing landscapes. Its financial fortitude is further bolstered by a judicious mix of pharmaceutical exports and local sales, highlighting its dual focus on global expansion and domestic consolidation. In this dance of science and commerce, Guangdong Hec Technology continues to solidify its stature, harnessing both innovation and keen business acumen to thrive in the ever-evolving pharmaceutical industry.
See Also
What is Guangdong Hec Technology Holding Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.1
CNY
Based on the financial report for Dec 31, 2025, Guangdong Hec Technology Holding Co Ltd's EPS (Diluted) amounts to 0.1 CNY.
What is Guangdong Hec Technology Holding Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
8%
Over the last year, the EPS (Diluted) growth was -31%. The average annual EPS (Diluted) growth rates for Guangdong Hec Technology Holding Co Ltd have been -41% over the past three years , -8% over the past five years , and 8% over the past ten years .